Dataset from Vitamin D to Improve Outcomes by Leveraging Early Treatment
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008643
下载链接
链接失效反馈官方服务：
资源简介：
Vitamin D deficiency is a common, potentially reversible contributor to morbidity and
mortality among critically ill patients. We conducted a randomized, double-blind,
placebo-controlled, phase 3 trial of early vitamin D3 supplementation in critically ill,
vitamin D-deficient patients who were at high risk for death. Patients screened as vitamin D
deficient (<20 ng/mL) were randomized. Randomization occurred within 12 hours after the
decision to admit the patient to an intensive care unit. Eligible patients received a single
enteral dose of 540,000 IU of vitamin D3 or matched placebo. The primary end point was 90-day
all-cause, all-location mortality.
创建时间：
2026-02-05
